MRK
$MRK
Merck & Co., Inc.
Global pharmaceutical leader known for Keytruda cancer immunotherapy and vaccines.
Healthcare$114.20
+0.00 (+0.00%)
Day Range$112.72 - $115.18
Prev Close$114.20
Analyst Rating
Strong Buy
24 Buy / 12 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Mar 22
Weekly updates
Latest Report
MRK: Valuation vs Keytruda Risk, Mixed Upside
Merck ($MRK) looks fundamentally strong with high ROE, solid cash flow and a 2.9% yield. Analysts are bullish on upside, but Keytruda patent pressure and stretched growth expectations keep the outlook balanced.
Mar 15, 2026